Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Mã chứng khoánPACB
Tên công tyPacific Biosciences of California Inc
Ngày IPOOct 27, 2010
Giám đốc điều hànhMr. Christian O. Henry
Số lượng nhân viên575
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhOct 27
Địa chỉ1305 O'brien Drive
Thành phốMENLO PARK
Sàn giao dịch chứng khoánNASDAQ Global Select Consolidated
Quốc giaUnited States of America
Mã bưu điện94025
Điện thoại16505218000
Trang webhttps://www.pacb.com/
Mã chứng khoánPACB
Ngày IPOOct 27, 2010
Giám đốc điều hànhMr. Christian O. Henry
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu